Article
Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.
Cancer discovery - 1 Apr 2013
Domchek Susan M, Tang Jiangbo, Stopfer Jill, Lilli Dana R, Hamel Nancy, Tischkowitz Marc, Monteiro Alvaro N A, Messick Troy E, Powers Jacquelyn, Yonker Alexandria, Couch Fergus J, Goldgar David E, Davidson H Rosemarie, Nathanson Katherine L, Foulkes William D, Greenberg Roger A
Abstract excerpt
UNLABELLED: BRCA1 and BRCA2 are the most important breast and ovarian cancer susceptibility genes. Biallelic mutations in BRCA2 can lead to Fanconi anemia and predisposition to cancers, whereas biallelic BRCA1 mutations have not been confirmed, presumably because one wild-type BRCA1 allele is required during embryogenesis. This study describes an individual who was diagnosed with ovarian carcinoma at age 28 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
